v3.25.1
Stockholders’ Equity
6 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Stockholders’ Equity

 

10. Stockholders’ Equity

 

Common Stock Transactions – Fiscal 2024

 

In July 2023, the Company issued 500,000 shares of common stock pursuant to a loan agreement.

 

In July 2023, the Company issued 109,637 shares of common stock pursuant to the Stock Purchase Agreement with Prakat Solutions Inc.

 

In September 2023, the Company issued 125,000 shares of common stock related to the acquisition of Watson.

 

In October 2023 the company issued 500,000 shares of common stock pursuant to a loan agreement.

 

In December 2023, the Company issued 125,000 shares of common stock related to the acquisition of Watson.

 

In December 2023, the Company issued 333,333 shares of common stock related to the acquisition of DepTec (SSCe).

 

In October 2023, November 2023 and December of 2023, the Company conducted a private placement whereby it raised $604,000 through the planned issuance of 4,666,666 shares of common stock. Refer to Note 14. Subsequent Events for the issuance of the related common stock shares.

 

Common Stock Transactions – Fiscal 2023

 

In July 2022, November 2022, December 2022, March 2023 and June 2023, the Company issued a total of 1,999,998 shares of common stock related to the acquisition of DepTec (SSCe).

 

In July 2022, the Company issued 500,000 shares of common stock pursuant to a consulting agreement for management services.

 

In December 2022, March 2023 and April 2023, the Company issued a total of 500,000 shares of common stock related to the acquisition of Watson.

 

In September 2022, December 2022, and March 2023, the Company issued a total of 375,000 shares of common stock related to the acquisition of International Health Group.

 

In September and December 2022, the Company issued a total of 175,000 shares of common stock related to the acquisition of Pacific Stem Cells. The are 87,500 shares of common stock remaining to be issued at a future date.

 

During the year ended June 30, 2023, the Company issued 10,974,521 shares of common stock pursuant to the conversion of $1,475,608 of convertible debt and its related premium and interest expense.

 

In April 2023, the Company issued 2,000,000 shares of common stock pursuant to a consulting agreement for management services to increase the investment community's awareness of the Company.